CLINICAL_TRIALS
withdrawal
· 2015-06-26
Clinical Trial Update: Intraarticular Injection of Infliximab [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 trial evaluating intraarticular infliximab for arthritis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: HaEmek Medical Center, Israel | Conditions: Arthritis | Phase 2, Phase 3 | Status: WITHDRAWN